Department of Pharmacology, Addiction Science, and Toxicology, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
Department of Pharmacology, Addiction Science, and Toxicology, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee
Mol Pharmacol. 2022 Mar;101(3):132-143. doi: 10.1124/molpharm.121.000392. Epub 2021 Dec 30.
Calcium- and voltage-gated K channels of large conductance (BKs) are expressed in the cell membranes of all excitable tissues. Currents mediated by BK channel-forming slo1 homotetramers are consistently inhibited by increases in membrane cholesterol (CLR). The molecular mechanisms leading to this CLR action, however, remain unknown. Slo1 channels are activated by increases in calcium (Ca) nearby Ca-recognition sites in the slo1 cytosolic tail: one high-affinity and one low-affinity site locate to the regulator of conductance for K (RCK) 1 domain, whereas another high-affinity site locates within the RCK2 domain. Here, we first evaluated the crosstalking between Ca and CLR on the function of slo1 (cbv1 isoform) channels reconstituted into planar lipid bilayers. CLR robustly reduced channel open probability while barely decreasing unitary current amplitude, with CLR maximal effects being observed at 10-30 M internal Ca CLR actions were not only modulated by internal Ca levels but also disappeared in absence of this divalent. Moreover, in absence of Ca, BK channel-activating concentrations of magnesium (10 mM) did not support CLR action. Next, we evaluated CLR actions on channels where the different Ca-sensing sites present in the slo1 cytosolic domain became nonfunctional via mutagenesis. CLR still reduced the activity of low-affinity Ca (RCK1:E379A, E404A) mutants. In contrast, CLR became inefficacious when both high-affinity Ca sites were mutated (RCK1:D367A,D372A and RCK2:D899N,D900N,D901N,D902N,D903N), yet still was able to decrease the activity of each high-affinity site mutant. Therefore, BK channel inhibition by CLR selectively requires optimal levels of Ca being recognized by either of the slo1 high-affinity Ca-sensing sites. SIGNIFICANCE STATEMENT: Results reveal that inhibition of calcium/voltage-gated K channel of large conductance (BK) (slo1) channels by membrane cholesterol requires a physiologically range of internal calcium (Ca) and is selectively linked to the two high-affinity Ca-sensing sites located in the cytosolic tail domain, which underscores that Ca and cholesterol actions are allosterically coupled to the channel gate. Cholesterol modification of BK channel activity likely contributes to disruption of normal physiology by common health conditions that are triggered by disruption of cholesterol homeostasis.
钙和电压门控大电导钾通道 (BK) 表达在所有可兴奋组织的细胞膜上。由 slo1 同源四聚体形成的 BK 通道介导的电流始终受到膜胆固醇 (CLR) 的增加的抑制。然而,导致这种 CLR 作用的分子机制仍然未知。Slo1 通道通过钙 (Ca) 在 slo1 胞质尾部中 Ca 识别位点附近的增加而被激活:一个高亲和力和一个低亲和力位点位于电导调节剂 (RCK) 1 域,而另一个高亲和力位点位于 RCK2 域内。在这里,我们首先评估了钙和 CLR 之间的串扰对重组到平面脂质双层中的 slo1 (cbv1 同工型) 通道功能的影响。CLR 强烈降低通道开放概率,而几乎不降低单位电流幅度,CLR 的最大作用在 10-30 M 内部 Ca 时观察到 CLR 作用不仅受到内部 Ca 水平的调节,而且在没有这种二价离子的情况下消失。此外,在没有 Ca 的情况下,激活 BK 通道的镁浓度 (10 mM) 不支持 CLR 作用。接下来,我们评估了 CLR 对 slo1 胞质结构域中存在的不同 Ca 感应位点通过突变变得无功能的通道的作用。CLR 仍然降低了低亲和力 Ca (RCK1:E379A,E404A) 突变体的活性。相反,当两个高亲和力 Ca 位点都突变时 (RCK1:D367A,D372A 和 RCK2:D899N,D900N,D901N,D902N,D903N),CLR 变得无效,但仍能够降低每个高亲和力位点突变体的活性。因此,CLR 对 BK 通道的抑制选择性地需要 slo1 两个高亲和力 Ca 感应位点之一识别的最佳 Ca 水平。意义表述:结果表明,膜胆固醇对钙/电压门控大电导钾通道 (BK) (slo1) 通道的抑制需要生理范围内的内部 Ca,并且与位于胞质尾部结构域中的两个高亲和力 Ca 感应位点选择性相关,这表明 Ca 和胆固醇的作用与通道门都是变构偶联的。BK 通道活性的胆固醇修饰可能通过破坏胆固醇稳态引发的常见健康状况对正常生理学造成干扰。